Patents by Inventor Jamil Talukder

Jamil Talukder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING PANCREATIC ENZYME DEFICIENCIES IN MAMMALS
    Publication number: 20230118104
    Abstract: A composition containing enzymes, L-arginine, and other components for treating exocrine pancreatic enzyme insufficiencies and gastrointestinal disorders in mammals. The compositions replace pancreatic enzymes while concurrently treating the side effects of small intestinal bacterial overgrowth and gastrointestinal mucosal degeneration that occurs with pancreatic enzyme loss. The composition can be mixed into animal feeds or sprayed onto extruded feeds prior to consumption.
    Type: Application
    Filed: November 30, 2022
    Publication date: April 20, 2023
    Inventors: Daniel J. DuBourdieu, Jamil Talukder, Rajiv Lall
  • Compositions and methods for treating pancreatic enzyme deficiencies in mammals
    Patent number: 11547745
    Abstract: A composition containing enzymes, L-arginine, and other components for treating exocrine pancreatic enzyme insufficiencies and gastrointestinal disorders in mammals. The compositions replace pancreatic enzymes while concurrently treating the side effects of small intestinal bacterial overgrowth and gastrointestinal mucosal degeneration that occurs with pancreatic enzyme loss. The composition can be mixed into animal feeds or sprayed onto extruded feeds prior to consumption.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: January 10, 2023
    Assignee: Vets Plus, Inc.
    Inventors: Daniel J. DuBourdieu, Jamil Talukder, Rajiv Lall
  • OVOTRANSFERRIN TREATMENT FOR THE REPRODUCTIVE TRACT
    Publication number: 20210128695
    Abstract: A composition and method of maintaining fertility or treating retained placenta, reproductive tract infection, or reproductive tract inflammation in an animal involves administering ovotransferrin to the reproductive tract of the animal. The ovotransferrin administration protects against and treats reproductive tract infection, while protecting against and treating reproductive tract inflammation such as metritis, and thereby maintains fertility in the animal.
    Type: Application
    Filed: January 12, 2021
    Publication date: May 6, 2021
    Applicant: Vets Plus, Inc.
    Inventors: Jamil Talukder, Abhijit Ray, Daniel J. DuBourdieu, Ajay Srivastava, Rajiv Lall
  • Ovotransferrin treatment for the reproductive tract
    Patent number: 10905748
    Abstract: A composition and method of maintaining fertility or treating retained placenta, reproductive tract infection, or reproductive tract inflammation in an animal involves administering ovotransferrin to the reproductive tract of the animal. The ovotransferrin administration protects against and treats reproductive tract infection, while protecting against and treating reproductive tract inflammation such as metritis, and thereby maintains fertility in the animal.
    Type: Grant
    Filed: April 16, 2018
    Date of Patent: February 2, 2021
    Assignee: VETS PLUS, INC.
    Inventors: Jamil Talukder, Abhijit Ray, Daniel J. DuBourdieu, Ajay Srivastava, Rajiv Lall
  • OVOTRANSFERRIN TREATMENT FOR THE REPRODUCTIVE TRACT
    Publication number: 20190314460
    Abstract: A composition and method of maintaining fertility or treating retained placenta, reproductive tract infection, or reproductive tract inflammation in an animal involves administering ovotransferrin to the reproductive tract of the animal. The ovotransferrin administration protects against and treats reproductive tract infection, while protecting against and treating reproductive tract inflammation such as metritis, and thereby maintains fertility in the animal.
    Type: Application
    Filed: April 16, 2018
    Publication date: October 17, 2019
    Applicant: Vets Plus, Inc.
    Inventors: Jamil Talukder, Abhijit Ray, Daniel J. DuBourdieu, Ajay Srivastava, Rajiv Lall